In early studies, p53 was considered an oncogene because of the lower expression level in normal cells compared with the cancerous one.10 In 1989, Levine et al. showed that wild-type p53 works as an oncosuppressor.11 Because of its important role in cancer biology, p53 has been defined “the guardian of the genome”. The gene discussed is TP53; the disease is cancer.